439 related articles for article (PubMed ID: 21057059)
21. Induction of cAMP response element modulator (CREM) and inducible cAMP early repressor (ICER) expression in rat brain by uncompetitive N-methyl-D-aspartate receptor antagonists.
Storvik M; Lindén AM; Kontkanen O; Lakso M; Castrén E; Wong G
J Pharmacol Exp Ther; 2000 Jul; 294(1):52-60. PubMed ID: 10871295
[TBL] [Abstract][Full Text] [Related]
22. The Alzheimer's disease drug memantine increases the number of radial glia-like progenitor cells in adult hippocampus.
Namba T; Maekawa M; Yuasa S; Kohsaka S; Uchino S
Glia; 2009 Aug; 57(10):1082-90. PubMed ID: 19115386
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
[TBL] [Abstract][Full Text] [Related]
24. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
Song MS; Rauw G; Baker GB; Kar S
Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
[TBL] [Abstract][Full Text] [Related]
25. The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain.
Marvanová M; Lakso M; Pirhonen J; Nawa H; Wong G; Castrén E
Mol Cell Neurosci; 2001 Sep; 18(3):247-58. PubMed ID: 11591126
[TBL] [Abstract][Full Text] [Related]
26. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
Gbahou F; Davenas E; Morisset S; Arrang JM
J Pharmacol Exp Ther; 2010 Sep; 334(3):945-54. PubMed ID: 20530654
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
Geerts H; Grossberg GT
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
[TBL] [Abstract][Full Text] [Related]
28. [The histaminergic system: a target for innovative treatments of cognitive deficits].
Motawaj M; Burban A; Davenas E; Gbahou F; Faucard R; Morisset S; Arrang JM
Therapie; 2010; 65(5):415-22. PubMed ID: 21144476
[TBL] [Abstract][Full Text] [Related]
29. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
30. Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration.
Borre Y; Bosman E; Lemstra S; Westphal KG; Olivier B; Oosting RS
Neuropharmacology; 2012 Apr; 62(5-6):2010-7. PubMed ID: 22248638
[TBL] [Abstract][Full Text] [Related]
31. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
32. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice.
Unger C; Svedberg MM; Yu WF; Hedberg MM; Nordberg A
J Pharmacol Exp Ther; 2006 Apr; 317(1):30-6. PubMed ID: 16354790
[TBL] [Abstract][Full Text] [Related]
33. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
[TBL] [Abstract][Full Text] [Related]
34. CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease.
Motawaj M; Peoc'h K; Callebert J; Arrang JM
J Alzheimers Dis; 2010; 22(3):861-71. PubMed ID: 20858978
[TBL] [Abstract][Full Text] [Related]
35. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.
Giustizieri M; Cucchiaroni ML; Guatteo E; Bernardi G; Mercuri NB; Berretta N
J Pharmacol Exp Ther; 2007 Aug; 322(2):721-9. PubMed ID: 17496164
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
Radenovic L; Selakovic V
Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
[TBL] [Abstract][Full Text] [Related]
37. The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.
Rammes G; Mahal B; Putzke J; Parsons C; Spielmanns P; Pestel E; Spanagel R; Zieglgänsberger W; Schadrack J
Neuropharmacology; 2001 May; 40(6):749-60. PubMed ID: 11369029
[TBL] [Abstract][Full Text] [Related]
38. Memantine facilitates memory consolidation and reconsolidation in the day-old chick.
Samartgis JR; Schachte L; Hazi A; Crowe SF
Neurobiol Learn Mem; 2012 May; 97(4):380-5. PubMed ID: 22425751
[TBL] [Abstract][Full Text] [Related]
39. Effects of the uncompetitive nmda receptor antagonist memantine on recognition memory in rats.
Dashniani M; Burjanadze M; Beselia G; Chkhikvishvili N; Naneishvili T
Georgian Med News; 2010 Jun; (183):27-33. PubMed ID: 20622272
[TBL] [Abstract][Full Text] [Related]
40. Ciproxifan, a histamine H₃-receptor antagonist / inverse agonist, modulates methamphetamine-induced sensitization in mice.
Motawaj M; Arrang JM
Eur J Neurosci; 2011 Apr; 33(7):1197-204. PubMed ID: 21366724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
